Evanston, IL, United States of America

Bastian Vogeli

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Northwestern University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bastian Vogeli. Retrieved from https://idiyas.com/inventor/bastian-vogeli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bastian Vogeli and Cell-Free Antibody Expression.

Introduction

Bastian Vogeli is an inventor associated with Northwestern University in Evanston, Illinois. His patent work includes research on producing antibodies and related molecules through cell-free expression.

Latest Patents

Vogeli is listed as an inventor on 1 patent: “Cell-Free Expression of Antibodies, Antigen-Binding Fragments Thereof, and Antibody Derivatives.” The invention concerns methods for producing antibodies, antibody fragments, and derivatives without relying on intact living cells.

Career Highlights

Vogeli’s listed patent reflects work at the intersection of biotechnology and antibody production. Northwestern University is identified as the organization associated with his invention.

Collaborations

The patent lists Michael Christopher Jewett and Andrew Colin Hunt as fellow inventors, indicating a collaboration on cell-free antibody expression.

Conclusion

Bastian Vogeli’s patent contribution, developed in collaboration with fellow inventors at Northwestern University, focuses on cell-free production of antibodies and related molecules.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…